Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q91VN6

Entry ID Method Resolution Chain Position Source
AF-Q91VN6-F1 Predicted AlphaFoldDB

46 variants for Q91VN6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389268840 14 D>V No EVA
rs3389284701 15 E>A No EVA
rs3389268888 15 E>D No EVA
rs3389287891 16 A>S No EVA
rs3413000913 17 T>S No EVA
rs3389282329 19 G>R No EVA
rs3389282593 25 D>G No EVA
rs3389296630 73 D>E No EVA
rs3389282595 86 S>R No EVA
rs3389301875 90 Q>H No EVA
rs3389268869 101 R>G No EVA
rs3403439370 106 K>C* No EVA
rs3389301868 125 A>D No EVA
rs3389215084 125 A>S No EVA
rs3389215073 161 E>V No EVA
rs3389293787 164 R>W No EVA
rs3389287944 175 G>D No EVA
rs3389282551 178 P>R No EVA
rs3389268851 180 I>N No EVA
rs3389282572 185 E>D No EVA
rs3404304845 197 K>* No EVA
rs3389243038 206 P>S No EVA
rs3389242923 222 I>V No EVA
rs3389301897 238 P>R No EVA
rs3389243009 254 K>* No EVA
rs3403439407 263 I>F No EVA
rs3389287942 273 T>S No EVA
rs3389259892 296 L>I No EVA
rs3389215063 304 K>N No EVA
rs3389287868 321 P>S No EVA
rs3389278216 386 A>T No EVA
rs3389278183 408 V>I No EVA
rs3389284739 412 V>* No EVA
rs3389301934 434 P>A No EVA
rs3389282244 460 V>I No EVA
rs3389215074 461 A>S No EVA
rs3389242963 461 A>V No EVA
rs3404513571 487 V>E No EVA
rs3403501231 490 D>Y No EVA
rs3404322606 502 Q>R No EVA
rs3389268824 511 E>V No EVA
rs3389215051 536 I>N No EVA
rs3389259875 545 L>F No EVA
rs3411704143 577 G>R No EVA
rs3389287691 587 G>S No EVA
rs3403977986 607 S>C No EVA

No associated diseases with Q91VN6

5 regional properties for Q91VN6

Type Name Position InterPro Accession
domain Helicase, C-terminal 407 - 567 IPR001650
domain DEAD/DEAH box helicase domain 205 - 384 IPR011545
domain Helicase superfamily 1/2, ATP-binding domain 200 - 411 IPR014001
domain RNA helicase, DEAD-box type, Q motif 181 - 209 IPR014014
domain DDX41, DEAD-box helicase domain 192 - 397 IPR044113

Functions

Description
EC Number 3.6.4.13 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
catalytic step 2 spliceosome A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs.
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
spliceosomal complex Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.

6 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
metal ion binding Binding to a metal ion.
RNA binding Binding to an RNA molecule or a portion thereof.
RNA helicase activity Unwinding of an RNA helix, driven by ATP hydrolysis.

6 GO annotations of biological process

Name Definition
cell differentiation The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
cell population proliferation The multiplication or reproduction of cells, resulting in the expansion of a cell population.
cellular response to interferon-beta Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon.
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

18 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9V3C0 abs ATP-dependent RNA helicase abstrakt Drosophila melanogaster (Fruit fly) PR
Q9UJV9 DDX41 Probable ATP-dependent RNA helicase DDX41 Homo sapiens (Human) PR
Q91VC3 Eif4a3 Eukaryotic initiation factor 4A-III Mus musculus (Mouse) PR
Q61496 Ddx4 ATP-dependent RNA helicase DDX4 Mus musculus (Mouse) SS
Q62095 Ddx3y ATP-dependent RNA helicase DDX3Y Mus musculus (Mouse) SS
P16381 D1Pas1 Putative ATP-dependent RNA helicase Pl10 Mus musculus (Mouse) SS
Q62167 Ddx3x ATP-dependent RNA helicase DDX3X Mus musculus (Mouse) SS
Q9QY15 Ddx25 ATP-dependent RNA helicase DDX25 Mus musculus (Mouse) PR
Q61655 Ddx19a ATP-dependent RNA helicase DDX19A Mus musculus (Mouse) SS
Q501J6 Ddx17 Probable ATP-dependent RNA helicase DDX17 Mus musculus (Mouse) PR
Q8VDW0 Ddx39a ATP-dependent RNA helicase DDX39A Mus musculus (Mouse) PR
Q9Z1N5 Ddx39b Spliceosome RNA helicase Ddx39b Mus musculus (Mouse) PR
Q99MJ9 Ddx50 ATP-dependent RNA helicase DDX50 Mus musculus (Mouse) PR
Q61656 Ddx5 Probable ATP-dependent RNA helicase DDX5 Mus musculus (Mouse) PR
Q5Z6G5 Os06g0697200 DEAD-box ATP-dependent RNA helicase 35B Oryza sativa subsp japonica (Rice) PR
Q0E3X4 Os02g0150100 DEAD-box ATP-dependent RNA helicase 35A Oryza sativa subsp japonica (Rice) PR
Q9LU46 RH35 DEAD-box ATP-dependent RNA helicase 35 Arabidopsis thaliana (Mouse-ear cress) PR
Q9SZB4 RH43 Putative DEAD-box ATP-dependent RNA helicase 43 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MEDSEPERKR ARADEATAGG SRSEDEDEDD EDYVPYVPLR QRRQLLLQKL LQRRRKGATE
70 80 90 100 110 120
EEQQDSGSEP RGDEDDIPLG PQSNVSLLDQ HQHLKEKAEA RKESAKEKQL KEEEKILESV
130 140 150 160 170 180
AEGRALMSVK EMAKGITYDD PIKTSWTPPR YVLSMSEERH ERVRKKYHIL VEGDGIPPPI
190 200 210 220 230 240
KSFKEMKFPA AILRGLKKKG ILHPTPIQIQ GIPTILSGRD MIGIAFTGSG KTLVFTLPVI
250 260 270 280 290 300
MFCLEQEKRL PFSKREGPYG LIICPSRELA RQTHGILEYY CRLLQEDSSP LLRCALCIGG
310 320 330 340 350 360
MSVKEQMETI RHGVHMMVAT PGRLMDLLQK KMVSLDICRY LALDEADRMI DMGFEGDIRT
370 380 390 400 410 420
IFSYFKGQRQ TLLFSATMPK KIQNFAKSAL VKPVTINVGR AGAASLDVIQ EVEYVKEEAK
430 440 450 460 470 480
MVYLLECLQK TPPPVLIFAE KKADVDAIHE YLLLKGVEAV AIHGGKDQEE RTKAIEAFRE
490 500 510 520 530 540
GKKDVLVATD VASKGLDFPA IQHVINYDMP EEIENYVHRI GRTGRSGNTG IATTFINKAC
550 560 570 580 590 600
DESVLMDLKA LLLEAKQKVP PVLQVLHCGD ESMLDIGGER GCAFCGGLGH RITDCPKLEA
610 620
MQTKQVSNIG RKDYLAHSSM DF